MSD Australia endorses new medicines strategic agreement

8 September 2021 - MSD Australia has today welcomed the signing of a new Medicines Strategic Agreement between Medicines Australia ...

Read more →

Landmark new medicines agreements to bring significant benefits for Australian patients

7 September 2021 - Australians will have more affordable, improved and guaranteed access to medicines under landmark long-term strategic agreements between ...

Read more →

New strategic agreements with the medicines industry

7 September 2021 - The Australian Government has entered into new strategic agreements with Medicines Australia and the Generic and ...

Read more →

Pharmaceutical companies should pay for raiding nature's medicine cabinet

11 August 2021 - In 2019, the pharmaceutical industry profited from US$1·2 trillion of global spending on medicines. Most of this ...

Read more →

PhRMA’s misleading description of Medicare drug price legislation

10 August 2021 - “They want to repeal a protection in Medicare that protects access to my medicines. They call ...

Read more →

What are the obligations of pharmaceutical companies in a global health emergency?

5 August 2021 - During a global health emergency, everyone is morally required to help to combat the disease.  ...

Read more →

Making pharmaceutical companies report what matters about innovation

29 July 2021 - There is a lack of transparency about the cost of innovation of the pharmaceutical industry even ...

Read more →

Pharma CEOs, lobbyists showered Democrat with cash after his attempt to torpedo Pelosi’s drug pricing bill

20 July 2021 - The very next day after Republican Scott Peters attempted to torpedo House Speaker Nancy Pelosi’s signature drug ...

Read more →

House report: drug companies spent more on buybacks, dividends than research

8 July 2021 - House Democrats on Thursday released a report that found that the 14 leading drug companies paid ...

Read more →

Success rate for marketing authorisation applications from SMEs doubles between 2016 and 2020

28 June 2021 - EMA has published today a report highlighting the Agency’s support for micro, small and medium sized ...

Read more →

FDA’s decision on Biogen Alzheimer’s drug will be a watershed moment for the agency — and the biotech industry

4 June 2021 - In the coming days the FDA will make one of its most important — and controversial — ...

Read more →

Congress loves a big pharma villain. But will that lead to any real policy changes on drug prices?

21 May 2021 - There's a funny cycle that resurfaces every now and then within the life sciences industry.  ...

Read more →

Katie Porter brings her whiteboard to accuse pharma CEO of inflating drug prices

19 May 2021 - Rep. Katie Porter (D-Calif.) went viral on social media after she brought back her signature whiteboard ...

Read more →

Vaccine patent waivers deserve a warning label

13 May 2021 - The move to suspend patents on COVID-19 vaccines opens up a major risk to the way the ...

Read more →

The pharma industry needs to measure patient experience from the patients’ perspectives

10 May 2021 - The relationship between clinical outcomes and the patient experience — the sum of all of interactions ...

Read more →